Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “TUMOR”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01120249
What this trial is testing

S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery

Who this might be right for
Kidney Cancer
SWOG Cancer Research Network 1,545
Not applicableLooking for participantsNCT06398938
What this trial is testing

Evaluation of Ultraaccelerated High Dose Rate Intrauterine Interventional Radiotherapy

Who this might be right for
Locally Advanced Cervical Carcinoma
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 129
Not applicableUnknownNCT05735548
What this trial is testing

Tumors of the Peripheral Nervous System

Who this might be right for
Tumor of Peripheral Nerve
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 100
Not applicableStudy completedNCT01990248
What this trial is testing

An Observational Safety Study in Zelboraf (Vemurafenib)-Treated Patients With BRAF-V600 Mutation-Positive Unresectable or Metastatic Melanoma (ZeSS)

Who this might be right for
Malignant Melanoma
Hoffmann-La Roche 339
Testing effectiveness (Phase 2)Study completedNCT01524848
What this trial is testing

Pazopanib in Advanced Gastrointestinal Stromal Tumors Refractory to Imatinib and Sunitinib

Who this might be right for
Gastrointestinal Stromal Tumors
Scandinavian Sarcoma Group 72
Not applicableNot Yet RecruitingNCT07685548
What this trial is testing

AI-Driven Tumor Response Evaluation for Solid Tumors

Who this might be right for
Solid Tumor CancerNeoplasmsHepatocellular Carcinoma
Shanghai Zhongshan Hospital 6,120
Not applicableStudy completedNCT00793455
What this trial is testing

Outreach for Patients With Uncompleted Colorectal Cancer Screening Orders

Who this might be right for
Colorectal Cancer ScreeningPrevention & Control
Northwestern University 628
Testing effectiveness (Phase 2)WithdrawnNCT02432378
What this trial is testing

Intensive Locoregional Chemoimmunotherapy for Recurrent Ovarian Cancer Plus Intranodal DC Vaccines

Who this might be right for
Cancer of OvaryCancer of the OvaryNeoplasms, Ovarian+3 more
Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT01853878
What this trial is testing

Demonstrate the Benefit of a New Kind of Anti-cancer Treatment [PReferentially Expressed Antigen of MElanoma (PRAME) Immunotherapy] for Patients With Non-Small Cell Lung Cancer (NSCLC), After Removal of Their Tumor

Who this might be right for
Lung Cancer, Non-Small Cell
GlaxoSmithKline 137
Testing effectiveness (Phase 2)Looking for participantsNCT07423078
What this trial is testing

Window of Opportunity in Preserving Laryngeal Function Trial

Who this might be right for
Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M)Locally Advanced Laryngeal Squamous Cell CarcinomaHypopharyngeal Squamous Cell Carcinoma
Matthew Spector 87
Early research (Phase 1)Looking for participantsNCT06191978
What this trial is testing

A Phase Ia/Ib Open-label, Multiple Dose, Study to Determine the Recommended Dose, Evaluate PKs, PDs, Safety, and Activity of Venetoclax in Combination With Oral Decitabine/Cedazuridine (ASTX727) in Pediatric Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
M.D. Anderson Cancer Center 40
Large-scale testing (Phase 3)UnknownNCT01557478
What this trial is testing

Melatonin as Adjuvant Therapy in Breast Cancer Patients

Who this might be right for
Stage II and III Breast Cancer
Khon Kaen University 166
Not applicableUnknownNCT01710085
What this trial is testing

Value of Diffusion Weighted Magnetic Resonance Imaging in Detection of Recurrent Disease in Surgically Treated Cervical and Endometrial Cancer Patients

Who this might be right for
Cervical CancerEndometrial Cancer
Uludag University 100
Testing effectiveness (Phase 2)Looking for participantsNCT07223385
What this trial is testing

High Cardiovascular Risk Intervention With Cardio-Oncology Consultation for Prostate Cancer Following Androgen Receptor Pathway Inhibitor (ARPI) Therapy (Heart-Safe)

Who this might be right for
Prostate Cancer (Diagnosis)Prostate Cancer Stage IVCV Risk
Cedars-Sinai Medical Center 80
Not applicableStudy completedNCT00566085
What this trial is testing

New Technique as an Additional Diagnostic Tool for Women Undergoing Neoadjuvant Therapy for Breast Cancer

Who this might be right for
Breast Cancer
Mayo Clinic 20
Not applicableEnrolling By InvitationNCT06729736
What this trial is testing

Implementation of the ERAS in Colorectal Cancer Patients: a Single Arm Study

Who this might be right for
Colorectal Cancer
Seoul National University Hospital 500
Early research (Phase 1)Looking for participantsNCT06326411
What this trial is testing

Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors

Who this might be right for
OncologyMEK MutationRAF Gene Mutation+6 more
Nested Therapeutics, Inc 230
Testing effectiveness (Phase 2)UnknownNCT03141671
What this trial is testing

Randomized Phase II Study of Salvage XRT + ADT +/- Abiraterone and Apalutamide for Rising PSA After RP (FORMULA-509)

Who this might be right for
Prostate Cancer
Dana-Farber Cancer Institute 345
Testing effectiveness (Phase 2)Ended earlyNCT00006371
What this trial is testing

A Phase II Trial of Early Medical Adrenalectomy for "D0.5" Prostate Cancer

Who this might be right for
Prostate Cancer
H. Lee Moffitt Cancer Center and Research Institute 2
Not applicableStudy completedNCT02486471
What this trial is testing

Hemostatic Procedure After Biopsy of the Cervix

Who this might be right for
Uterine Cervical Dysplasia
Zydolab - Institute of Cytology and Immune Cytochemistry 166
Next Page